Abstract
Implantable left ventricular assist device (LVAD) drive-line exit site infection, an expected consequence of currently available device use, continues to be a significant limiting factor in long-term support. We theorize that the mechanism behind the establishment of the most chronic exit site infections involves a shearing torsion injury that disrupts the tissue adherence interface with the drive-line. The resulting neo-epithelialized drainage tract prevents permanent clearance of the infection with antibiotics alone. The proposed treatment strategy of established infections involves aggressive surgical excision of the involved exit site.
| Original language | English |
|---|---|
| Pages (from-to) | 1267-1268 |
| Number of pages | 2 |
| Journal | Annals of Thoracic Surgery |
| Volume | 74 |
| Issue number | 4 |
| DOIs | |
| State | Published - Oct 1 2002 |
Fingerprint
Dive into the research topics of 'Surgical management of novacor drive-line exit site infections'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver